ASK REDCHAT ANYTHING ABOUT KORRO BIO INC.
Korro Bio Inc. (NASDAQ: KRRO)
Listen to this Section
$14.43
-0.1350
(
-0.93% )
208.2K
Sign up for The Small Stocks Big Money Newsletter and receive free small-cap news and insights.
Clinical Trial Pipeline Stages
| Drug Name |
Stage |
| KRRO-110DetailsAlpha-1 Antitrypsin Deficiency |
Phase 1/2 |
| FX-322DetailsEar disease, Sensorineural hearing loss |
Failed |
| FX-345DetailsSensorineural hearing loss, Ear disease |
Failed |
Market Data
|
| Open |
$14.43 |
| Previous Close |
$14.56 |
| Volume |
208.2K |
| Market Cap |
$209.99M |
| Day Range |
$13.42 - $15.05 |
| 52 Week Range |
$5.20 - $55.89 |
| Shares Outstanding |
14.42M |
| Change % |
-0.93% |
| Net Change |
▼ -0.1350 |
| Insider Ownership |
-0.01% |
| Exchange |
NASDAQ |
| Sector | Healthcare |
| Industry | Biotechnology: Pharmaceutical Preparations |
| IPO Year | 2023 |
| Country | United States |
| Underwriter | IPO Intelligence Only |
Insider Ownership Transactions
Total Amount Purchased:
-2,193,413.00
| Date |
Type |
Amount Purchased |
Purchaser |
| 2023-11-27 |
Sale |
-110.00 |
Lucchino David L. |
| 2023-11-22 |
Sale |
-5600.00 |
Lucchino David L. |
| 2023-11-07 |
Sale |
-942075.00 |
FORMELA JEAN FRANCOIS |
| 2023-11-07 |
Sale |
-51896.00 |
Colletti Steve |
| 2023-11-07 |
Sale |
-23723.00 |
Walker Shelby J. |
| 2023-11-07 |
Sale |
-35114.00 |
Bermingham Nessan |
| 2023-11-07 |
Sale |
-13625.00 |
Chappell Todd |
| 2023-11-07 |
Sale |
-4613.00 |
Aiyar Ram |
| 2023-11-07 |
Sale |
-40870.00 |
Agarwal Vineet |
| 2023-11-07 |
Sale |
-16000.00 |
PEARSON TIMOTHY R |